Medical device maker Stryker was not in discussions to buy rival Boston Scientific, Stryker said in a regulatory filing on Wednesday, two days after reports of a potential deal between the two surfaced.
“Stryker is usually not in discussions with Boston Scientific Corporation regarding a potential acquisition,” Stryker said on Wednesday.
Stryker’s shares rose 5.8 percent to $172.01 in premarket trading, while Boston Scientific’s shares fell 5.4 percent to $32.01.
The Wall Street Journal had reported on Monday that will Stryker had made a takeover approach to Boston Scientific.
the idea was not clear whether Boston Scientific was open to a potential acquisition by Stryker, the Journal had reported.